Informational needs assessment of non-Hodgkin lymphoma survivors and their physicians

被引:20
|
作者
Friedman, Daphne R. [1 ]
Coan, April D. [2 ]
Smith, Sophia K. [2 ,3 ]
Herndon, James E., II [2 ,4 ]
Abernethy, Amy P. [1 ,2 ]
机构
[1] Duke Univ, Med Ctr, Dept Med, Durham, NC 27705 USA
[2] Duke Univ, Med Ctr, Duke Comprehens Canc Ctr, Durham, NC 27710 USA
[3] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA
[4] Duke Univ, Dept Biostat & Bioinformat, Durham, NC 27705 USA
关键词
CANCER SURVIVORS; CARE;
D O I
10.1002/ajh.21725
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cancer Survivorship Care Plans (SCPs) are a recommended part of medical care for cancer survivors. We sought to identify the medical and psychosocial informational needs of non-Hodgkin lymphoma survivors and their physicians in cancer survivorship care to be included in SCPs. Questionnaires were mailed to eligible lymphoma survivors and their physicians, querying their preferences about informational needs in SCPs. The survivor cohort had a median age at diagnosis of 62, with 57% Female, 87% White, and 76% from North Carolina. The physician cohort was comprised of oncologists (27%) and nononcologists (73%), and 86% practiced in North Carolina. Greater than 60% of both survivors and physicians preferred an oncologist and primary care provider comanage cancer survivorship care. The most highly rated informational needs were medical issues, although there were differences between survivors and physicians for many of the informational needs queried. There was higher concordance between patient and physician responses for medical issues (63 to 100%) compared to psychosocial issues (25 to 63%). Important components of SCPs for lymphoma survivors and their physicians may go unrecognized. Tailoring SCPs to patient or physician users may better accommodate the differences in need for particular cancer survivorship care information.
引用
收藏
页码:528 / 532
页数:5
相关论文
共 50 条
  • [41] Glomerulonephritis and non-Hodgkin lymphoma
    Harper, L
    Adu, D
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (07) : 1520 - 1525
  • [42] DIAGNOSIS OF NON-HODGKIN LYMPHOMA
    WUTKE, K
    RUDIGER, KD
    ZEITSCHRIFT FUR KLINISCHE MEDIZIN-ZKM, 1989, 44 (08): : 661 - 666
  • [43] Non-Hodgkin lymphoma of the breast
    Ganjoo, Kristen
    Advani, Ranjana
    Mariappan, M. Rajan
    McMillan, Alex
    Horning, Sandra
    CANCER, 2007, 110 (01) : 25 - 30
  • [44] NON-HODGKIN LYMPHOMA AND CARBAMAZEPINE
    OKEANE, JC
    LANCET, 1989, 2 (8674): : 1275 - 1276
  • [45] ENDOBRONCHIAL NON-HODGKIN LYMPHOMA
    LOISON, F
    PATRI, B
    VILDE, F
    RAY, B
    THIBIER, G
    BROUSSARD, O
    DUBRISAY, J
    SEMAINE DES HOPITAUX, 1984, 60 (10): : 698 - 700
  • [46] Pathergy in non-Hodgkin lymphoma
    Burney, IA
    Moatter, T
    Siddiqui, T
    Yaqoob, N
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2003, 96 (03) : 127 - 129
  • [47] The epidemiology of non-Hodgkin lymphoma
    Grulich, AE
    Vajdic, CM
    PATHOLOGY, 2005, 37 (06) : 409 - 419
  • [48] Non-Hodgkin lymphoma in the elderly
    Dupuis, Jehan
    Haioun, Corinne
    BULLETIN DU CANCER, 2008, 95 : F79 - F83
  • [49] Non-Hodgkin Lymphoma Metabolism
    Kirsch, Brian James
    Chang, Shu-Jyuan
    Le, Anne
    HETEROGENEITY OF CANCER METABOLISM, 2018, 1063 : 95 - 106
  • [50] HCV and non-Hodgkin lymphoma
    Hanley, J
    Jarvis, L
    Simmonds, P
    Parker, A
    Ludlam, C
    LANCET, 1996, 347 (9011): : 1339 - 1339